In the last trading session, 15,415,689 shares of the Vaccinex, Inc.(NASDAQ:VCNX) were traded, and its beta was 0. Most recently the company’s share price was $5.11, and it changed around $0.23 or 0.05% from the last close, which brings the market valuation of the company to $114.39 Million. VCNX currently trades at a discount to its 52-week high of $9.56, offering almost -87.08% off that amount. The share price’s 52-week low was $1.63, which indicates that the current value has risen by an impressive 68.1% since then. We note from Vaccinex, Inc.’s average daily trading volume that its 10-day average is 55.91 Million shares, with the 3-month average coming to 5.19 Million.
Vaccinex, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended VCNX as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Vaccinex, Inc. is expected to report earnings per share of -$0.37 for the current quarter.
Vaccinex, Inc. (NASDAQ:VCNX): Trading Information
Instantly VCNX has showed a green trend with a performance of 4.71% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $9.56- on Friday, Feb 19 increased the stock’s daily price by 46.55%. The company’s shares are currently up 1.47% year-to-date, but still up 0.6019 over the last five days. On the other hand, Vaccinex, Inc. (NASDAQ:VCNX) is 1% up in the 30-day period. We can see from the shorts that 253.12 Million shares have been sold at a short interest cover period of 48.77 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bears needing to increase their stock price by 36.99% from its current value. Analyst projections state that VCNX is forecast to be at a low of $7 and a high of $7. In order for the stock price to hit the forecast high, the stock would need to surge +36.99% from its current level, while the stock would need to crash 36.99% from its current level to reach the projected low.
Vaccinex, Inc. (VCNX) projections and forecasts
Vaccinex, Inc. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -10.35 percent over the past six months and at a 36.84% annual growth rate that is well above the industry average of 14%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +2.6% in revenue this quarter, and will report an increase of 6.7% in the next quarter. The year-over-year growth rate is expected to be 14.7%, up from the previous year.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. Vaccinex, Inc. earnings are expected to increase by 3.8% in 2021, but the outlook is negative 0% per year for the next five years.
Vaccinex, Inc. (NASDAQ:VCNX)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 18.4% of Vaccinex, Inc. shares, and 50.4% of them are in the hands of institutional investors. The stock currently has a share float of 61.76%. Vaccinex, Inc. stock is held by 27 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Sep 29, 2020, it held 0.64% of the shares, which is about 142.3 Thousand shares worth $253.29 Thousand.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Telemetry Investments, L.L.C., with 0.26% or 58.3 Thousand shares worth $103.77 Thousand as of Sep 29, 2020, holds the second largest percentage of outstanding shares.